Novo Nordisk has reported the first mid-stage clinical data with its triple G agonist for diabetes in China, as it starts an international trials programme. The drug candidate, UBT251, acts on GLP-1, ...
Even if you aren’t using Google Gemini, it might be using your device. Security researcher Alexander Hanff, also known as ...
Solana Foundation and Google Cloud launched Pay.sh for AI agent stablecoin payments. Agents tap Gemini, BigQuery, and Vertex AI without accounts or subscriptions. The system uses the x402 protocol for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results